[Commentary on] Outpatient taxol and carboplatin chemotherapy for suboptimally debulked epithelial carcinoma of the ovary results in improved quality of life: an Eastern Cooperative Oncology Group Phase II Study (E2E93)
Title
[Commentary on] Outpatient taxol and carboplatin chemotherapy for suboptimally debulked epithelial carcinoma of the ovary results in improved quality of life: an Eastern Cooperative Oncology Group Phase II Study (E2E93)
Creator
von Gruenigen V E
Publisher
Women's Oncology Review
Date
2001
2001-06
Subject
Female; Quality of Life; Disease Progression; Outpatients; Drug Therapy; Combination; Carboplatin; Carcinoma – Drug Therapy; Ovarian Neoplasms – Drug Therapy; Paclitaxel – Therapeutic Use
Rights
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
Pages
149–150
Issue
2
Volume
1
Citation
von Gruenigen V E, “[Commentary on] Outpatient taxol and carboplatin chemotherapy for suboptimally debulked epithelial carcinoma of the ovary results in improved quality of life: an Eastern Cooperative Oncology Group Phase II Study (E2E93),” NEOMED Bibliography Database, accessed April 28, 2024, https://neomed.omeka.net/items/show/6120.